Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Researchers at the Kennedy Institute of Rheumatology at the University of Oxford mapped dopamine and the consequences of its release to the immunological synapse.

© richardlewisohn.co.uk

The neurotransmitter dopamine, long associated with reward-motivated behaviour in the brain, has been shown to play a key role in the human immune response in an article published this week in Nature. The research has demonstrated for the first time how human immune cells use dopamine, in specialised vesicles localized to the immunological synapse, to accelerate the immune response. This work can now be used as a basis for the development of new therapies to treat immune diseases and improve vaccines.

The collaborative research involving groups from Australia, Italy, Germany and the UK predicts that the neurotransmitter dopamine is used to accelerate antibody production in humans, which helps us to fight off infections more quickly. The dopamine is released from specialised immune cells, called helper T lymphocytes, which use cellular machinery normally found in neurons to allow the release of the neurotransmitter into the immunological synapse formed with antibody producing B lymphocytes.  The groups of Carola Vinuesa at the Australian National University and Claudio Dongoli at San Raffaele Scientific Institute, Milan discovered dopamine production by a rare T cell subset in the tissue region in humans associated with high affinity antibody production, and the immediate impact of dopamine on antibody producing cells.  Dr. David Saliba, Mr Salvatore Valvo and Prof Mike Dustin’s group in the Kennedy Institute, University of Oxford demonstrated how this machinery is positioned within the immunological synapse of the T lymphocytes and identified the signal stimulated by the released dopamine.   The group of Michael Meyer-Herman at Hemlotz Centre, Germany then used a modelling approach to predict that dopamine accelerates antibody production compared to responses in laboratory mice, which lack this mechanism.  The lead author, Ilenia Papa, coordinated all the efforts across all the centres.

Dr. Saliba says, "This study has highlighted important parallels of cellular communication in the immune and nervous systems. Using state of the art facilities at the Kennedy Institute of Rheumatology we were able to visualize the location of dopamine containing vesicles and the consequence of dopamine communication across the immunological synapse."

The work was funded in part by Human Frontiers Science Program, an organisation funded by the G7 nations and European Commission to support international collaboration. Prof Dustin, who has been working on the immunological synapse since the 1990s, highlighted the importance of such interactions, “This is a great example of international collaboration as the conclusions would not be possible without unique contributions from experts based in 4 nations.”

Similar stories

Immunology preprint reviews launched in Nature Reviews Immunology

Kennedy Main Research

The Oxford-Mount Sinai (OxMS) Preprint Journal Club has partnered with Nature Reviews Immunology to launch a monthly Preprint Watch column.

A more tailored approach to treating psoriatic arthritis

Arthritis Botnar Funding Main

Dr Laura Coates has been awarded £1.8M from the National Institute for Health Research (NIHR) to explore the potential for precision medicine in the choice of biologics to reduce inflammation and pain in psoriatic arthritis.

Motion-capture to help children walk: Oxford team support new gait laboratory in Ethiopia

Main Orthopaedics and trauma

The Research at Oxford on Analysis of Motion (ROAM) team at the University of Oxford have supported CURE Ethiopia Children’s Hospital to develop and open a brand new gait laboratory, the first of its kind in the country and the only other active gait lab on the African continent outside of South Africa.

Professor Eleanor Stride recognised in New Year’s Honours list 2021

Awards Main

Statutory Professor of Biomaterials is awarded Officer of the Order of the British Empire (OBE) for services to Engineering

Drug may boost vaccine responses in older adults

Kennedy Main

A preliminary study shows that a drug which helps immune cells self-clean may improve vaccine protection in older adults

Living reviews launched by Oxford and Cardiff in the wake of COVID-19 research

Kennedy Main Research

In a combined effort to help COVID-19 researchers the University of Oxford and Cardiff University have launched a series of “living reviews” in Oxford University Press’s new open access journal “Oxford Open Immunology”.